H1 2024 revenue grew 2.86% to ¥10.55B and net profit rose 19.71% to ¥2.05B, driven by network expansion, international acquisitions, and robust demand for ophthalmic services.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.